LRP130 antibody [N3C2], Internal
|Applications||ICC/IF, IHC-P, WB|
Not tested in other applications.
|IHC (Formalin-fixed paraffin-embedded sections)||1:100-1:1000*
*Optimal dilutions/concentrations should be determined by the researcher.
|Predicted Target Size||158 kDa (note)
|Positive Controls||293T , A431 , H1299 , HeLa , HepG2 , Molt-4 , Raji , mouse brain|
(Please refer to the vial label for the specific concentration)|
|Purification||Purified by antigen-affinity chromatography.|
|Full Name||leucine-rich PPR-motif containing|
|Product Description||Rabbit Polyclonal antibody to LRP130 (leucine-rich PPR-motif containing)|
|Background||This gene encodes a protein that is leucine-rich and is thought to play a role in regulating the interaction of the cytoskeleton with a variety of cellular processes. Mutations in this gene are associated with the French-Canadian type of Leigh syndrome. Transcripts ranging in size from 4.8 to 7.0 kb which result from alternative polyadenylation have been reported for this gene. [provided by RefSeq]|
|Synonyms||CLONE-23970 antibody, GP130 antibody, LRP130 antibody, LSFC antibody, LRPPRC antibody, "leucine-rich PPR motif-containing protein, mitochondrial antibody", 130 kDa leucine-rich protein antibody, mitochondrial leucine-rich PPR motif-containing protein antibody, LRP 130 antibody, leucine-rich PPR-motif containing antibody|
|Cellular Localization||Mitochondrion , Nucleus , nucleoplasm , Nucleus inner membrane , Nucleus outer membrane |
|Immunogen||Recombinant protein encompassing a sequence within the center region of human LRP130. The exact sequence is proprietary.|
|Species Reactivity||Human, Mouse|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Predict Reactivity Note||Rat (85%)|